Marathon Patent Group Inc
Change company Symbol lookup
Select an option...
MARA Marathon Patent Group Inc
HNGR Hanger Inc
$RFTREES Refinitiv Eurozone ESG Select Index
NEMCF New Energy Metals Corp
SLCT Select Bancorp Inc
GOLD Barrick Gold Corp
DGNR Dragoneer Growth Opportunities Corp
EQMEF Equity Metals Corp
TS Tenaris SA

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Information Technology : IT Services | Small Cap Blend
Company profile

Marathon Patent Group, Inc. is a digital asset technology company. The Company focuses on the blockchain ecosystem and the generation of digital assets. The Company is operating one mining facility in Quebec, with plans to open additional facilities in the future. The Company offers managed mining solutions on its robust proprietary infrastructure and smart mining software. The Company intends to power and secure blockchains by verifying blockchain transactions using custom hardware and software. It is using its hardware to mine bitcoin (BTC) and expect to mine BTC and ether (ETH), and potentially other cryptocurrencies.

Day's Change
-3.10 (-13.87%)
B/A Size
Day's High
Day's Low

Today's volume of 33,342,265 shares is on pace to be in-line with MARA's 10-day average volume of 70,059,934 shares.


Cardinal's stock rises 2%; company had a $130 million impact as a result of the pandemic in the quarter

7:27 am ET August 6, 2020 (MarketWatch)

Shares of Cardinal Health Inc. (CAH) rallied 2.4% after the medical distributor reported better-than-expected earnings for its fiscal fourth quarter. The company had earnings of $656 million, or $2.23 a share, in the fourth quarter of 2020, up from $194 million, or 65 cents a share, in the same quarter a year ago. Adjusted earnings per share were $1.04, against a FactSet consensus of 90 cents. Cardinal said earnings for the quarter had a net negative impact of approximately $130 million as a result of people avoiding visits to the doctor and delaying elective procedures during the COVID-19 pandemic. It had also a $579 million pre-tax gain due to the sale of its stake in a company that owned NaviHealth, a post-acute care company that was sold to UnitedHealth Group's Optum in May. Cardinal reported $36.7 billion in revenue for the quarter, down 2% from $37.4 billion in the quarter a year ago. The FactSet consensus was $36.8 billion in revenue. Pharmaceutical sales were flat, at $33.2 billion, while medical segment sales fell 13% to $3.5 billion. Cardinal's stock has gained 13.9% year-to-date. The S&P 500 is up 3.0% for the year.

-Jaimy Lee; 415-439-6400;

(END) Dow Jones Newswires

August 06, 2020 07:27 ET (11:27 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.